This paper describes the generation of monodisperse calcium alginate (Ca-alginate) microcapsules on a microfluidic platform using the commercial optical disk process. Our strategy is based on combining the rapid injection molding process for a cross-junction microchannel with the sheath focusing effect to form uniform water-in-oil (w/o) emulsions. These emulsions, consisting of 1.5% (w/v) sodium alginate (Na-alginate), are then dripped into a solution containing 20% (w/v) calcium chloride (CaCl 2 ) creating Ca-alginate microparticles in an efficient manner. This paper demonstrates that the size of Ca-alginate microparticles can be controlled from 20 µm to 50 µm in diameter with a variation of less than 10%, simply by altering the relative sheath/sample flow rate ratio. Experimental data show that for a given fixed dispersed phase flow (sample flow), the emulsion size decreases as the average flow rate of the continuous phase flow (sheath flow) increases. The proposed microfluidic platform is capable of generating relatively uniform emulsions and has the advantages of active control of the emulsion diameter, a simple and low cost process and a high throughput.
Introduction
Polymer-based technologies (CO 2 -laser, hot-embossing, mold injection, lithography electroforming micro molding (LIGA), LIGA-like and others) have been widely applied to fabricate biomedical devices that meet the requirements of low cost, flexible process and have the capability of being massproduced [1] [2] [3] [4] . However, high cost and/or a long cycle time limits their application [5] [6] [7] [8] . For example, when the conventional optical disk technique (mold injection) is used for fabricating the microfluidic substrate, the mold insert induces an opposite electroform pattern on the backside. Generally speaking, this backside pattern of the mold insert damages the mold. Therefore, the mold insert must be polished prior to being integrated with the mold. However, this backside polishing process must be well controlled so as to prevent overstress, since overstressing will warp the mold insert and causes a loss of vacuum. Recently, we proposed a new method for a mold insert, and it overcomes the problems above [9] . We also use it for the fabrication of microfluidic substrates, putting great emphasis on the parameters of the fabrication process and the material characteristics. In the present study, we focus on the further application of this new technique for mass production of microfluidic disks. We also design a new pattern for the microchannel cross-junction, and apply it in the generation of calcium alginate (Ca-alginate) microcapsules. Ca-alginate is currently receiving a great deal of attention for medical applications and for the controlled release of drugs [10] . To date, the production of Ca-alginate microcapsules has been accomplished mainly by using external gelation (dripping method). For example, sodium alginate (Na-alginate) is extruded dropwise through a needle into a solution of divalent cations, which induces crosslinking of the guluronic residues of the alginate polymer [11] [12] [13] [14] . The alternative techniques are as follows: (i) atomization (spray-drying) [15, 16] , (ii) coacervation [17] , (iii) emulsification (internal/external gelation) [18] [19] [20] [21] and other methods. However, all of these techniques have well-known drawbacks such as unstable yield, tedious procedures and non-uniform particle sizes with a wide size distribution. Consequentially, it has become imperative for the pharmaceutical industry to develop a reproducible method for generating Ca-alginate microcapsules in a controlled manner, with a uniform particle size and a narrow size distribution.
Microfluidic emulsification has been used for the fabrication of monodisperse water-in-oil (w/o), oil-in-water (o/w) emulsions and for bubbles, and then for creating monodisperse polymeric microparticles by curing emulsion droplets containing a monomer solution [22] [23] [24] [25] [26] [27] [28] [29] . Recently, we proposed a novel microfluidic device that utilized a polymethylmethacrylate (PMMA) microfluidic chip to produce 50-2000 µm Ca-alginate microcapsules with a variation within 5% [30] . However, using a CO 2 -laser machine or making a microfluidic structure on a PMMA sheet is not suitable for mass production. Also, the smallest width of the microfluidic channel is limited to 200 µm. In addition, this method is not sufficiently precise, nor is it suitable for the prototype since it will damage the surface of the substrate of the microfluidic channel.
The fabrication process for the microfluidic chip in this study is shown in figure 1 . The industrial high-speed injection machine, Sumitomo SD-35E, and the Seiko Giken F-type optical disk mold (the use of which was provided to us by RITEK Corporation, Hsinchu, Taiwan, ROC) were employed to fabricate the microfluidic chip. Except for the fabrication of the mold insert, the injection molding process of the microfluidic chip is the same as the conventional optical disk process [3, 9] . Therefore, the fabrication process proposed in this study is a time-saving, low-cost, flexible process. It has high-resolution, multi-functional structures on a uni-substrate, and it is suitable for mass production. In addition, we applied the proposed disk microfluidic chip for the generation of 20-50 µm monodisperse Ca-alginate microcapsules. The inference between the emulsion size and flow rate, and the encapsulation of immunoglobulin (IgG) and gold nanoparticles (AuNPs) were also studied.
Materials and methods

Materials
The material of the microfluidic substrates in this experiment is optical grade polycarbonate (PC, AD5503, Teijin Corporation, Japan). The glass transition temperature is approximately 145
• C. The cylinder temperature is controlled from 320 • C to 380
• C, and the temperature of the stationary-side mold is controlled from 100
• C to 120
• C. The commercial sample of low-viscosity Na-alginate (viscosity 250 mPa s in 1.5% (w/v) solution at 25
• C; brown algae) was purchased from Sigma Chemical Co. (MO, USA). Sunflower seed oil (viscosity 55 mPa s) was purchased from Uni-President Enterprises Corp., Taiwan. Human serum IgG was purchased from SigmaAldrich Co. All other chemicals (calcium chloride purchased from Panreac Quimica SA) were of analytical grade and were used without further purification.
Preparation of gold nanoparticles (AuNPs)
In a 250 mL round-bottom flask equipped with a condenser, 100 mL of 1 mM HAuCl 4 was brought to rolling boil while being stirred vigorously. Then 10 mL of 38.8 mM sodium citrate was quickly added to the vortex of the solution. The mixture was then heated to 55
• C in an oil bath with magnetic stirring until a deep-wine-red color was obtained, indicating the formation of a AuNPs suspension. The heating mantle was then removed, and stirring was continued for an additional 15 min. After the solution reached room temperature, it was filtered through a 0.8 µm Gellman membrane filter. The resulting solution of colloidal particles was characterized by an absorption maximum at 520 nm. The prepared AuNPs had a narrow distribution of particle size with a mean diameter of about 5 ± 0.8 nm (100 particles sampled). [9] In this study, the injection molding was conducted on a highspeed injection machine (Sumitomo SD-35E), and the Seiko Giken F-type optical disk mold was adopted. There are two steps to integrate the mold insert with the mold. First, the mold insert is hung on the fixture (figure 2(a)). Second, the vacuum system of the mold is used to keep the mold insert on the mirror plate ( figure 2(b) ). The details of the optical disk process are described as follows (figure 1). First, a piece of nickel (Ni) plate, 300 µm thick, was electroformed, and then the photoresist (PR) was coated 20-200 nm thick on its surface. Next, the PR on the Ni was exposed and developed. Finally, the Ni plate was electroformed into a 50 µm thick plate again, and then the mold insert (stamper) was finished. With the appropriate injection parameter adjusted, the plastic optical disk substrates could be fabricated. 
Microfluidic substrate molding
Principle of emulsification and gelation
Generating a narrow size distribution of self-assembling emulsions is based on the focusing force in the cross-junction channel ( figure 3(a) ). The mechanism of the microfluidic cross-junction provides a finer control of the emulsion sizes by varying the ratio between the dispersed and the continuous phase flow rates [31] . Based on the outstanding performance of the microfluidic platform, we utilized it in this work for pharmaceutics (e.g. Ca-alginate microcapsule generation). We report the use of microfluidics in our attempt to obtain control over the spontaneous self-assembly of water-in-oil (w/o) emulsions from a solution of dissolved Na-alginate. These semi-products (emulsions) were then dripped into a solution containing calcium (II) ions, resulting in the instantaneous formation of Ca-alginate microcapsules. The Figure 3 . Illustrations of the system mechanism: (a) a schematic drawing of a Na-alginate emulsion generator in a cross-junction microchannel, (b) the mechanism of Na-alginate polymerization: the chemical reaction in the reservoir consists of the sodium ions of the alginate being substituted by calcium ions, indicating the formation of Ca-alginate microcapsules and (c) a reservoir.
mechanism of the synthesis of Ca-alginate microcapsules consisted of the calcium (II) ions released by CaCl 2 undergoing crosslinking with Na-alginate emulsions and produced Caalginate microcapsules (external gelation, as shown in figure 3(b) ) [20] . Figure 4 shows an overview of the experimental setup. The procedure is as follows. First, the fluids of the center and side inlet channels were connected to 3 mL 1.5% (w/v) Na-alginate solution (dispersed phase) and 3 mL sunflower seed oil (continuous phase), respectively. The material to be encapsulated is mixed with an alginate solution. Second, the fluids are then injected into the microfluidic platform by syringe pumps (Kdscientific KDS230) programmed by a PC. In this work, we hydrodynamically focused a stream of Na-alginate solution at a cross-junction microchannel by means of two oil streams, enabling the construction of w/o Na-alginate emulsions in the microchannel. Finally, the Na-alginate emulsions then underwent gelation and were dripped into a calcium (II) ion solution to form Ca-alginate microcapsules.
Experimental procedure
Emulsion size measurement
An inverted fluorescent microscope was used to observe the experimental results. The image and detection system consisted of an optical microscope (BX60, Olympus, Japan) and a digital camera (DP70, Olympus, Japan). The diameter of each emulsion was measured and averaged. A total of 50 emulsions were measured to provide an average size.
Results and discussions
Injection molding system
This paper proposed an optical disk process for the mass production of a microfluidic substrate, as shown in figure 1 . The Ni plate was used in the process to prevent the backside pattern from being formed on the mold insert. Therefore, the mold insert created by our proposed method did not damage the mirror plate of the mold. In addition, in order to reduce the cycle time, the molding system was water cooled using a spiral cooling system behind the mirror plate ( figure 2(c) ). In addition, our molding system used a mold insert holder and a vacuum system to combine the mold insert and the mold, which substantially reduced the time required to change the mold insert.
The microfluidic platform
The platform consists of four layers from top to bottom (an expanded view is shown in figure 5(a) ): the cover layer (containing one outlet port and three inlet ports), the mesolayer (to prevent the fluids from leaking out), the microfluidic substrate (the cross-junction channel, depth/width: 50 µm/ 50 µm) and the bottom layer (the disk structure, 110 mm in diameter is designed in a modular fashion for placing on an inverted fluorescent microscope), respectively. The cover and bottom layers are both laid out on conventional PMMA using a CO 2 -laser machine (LaserPro Venus, GCC, Taiwan). The meso-layer was fabricated with polydimethylsiloxane (PDMS) by PMMA molding. Finally, these four layers are fastened together with screws (see figure 5(b) ). The cross-junction we used in this study has three inlet ports, one outlet port, one cross channel (50 µm wide) and an observation area, as shown in figure 5 (b). The observation area (400 µm wide, much wider than the cross channel) is designed to slow down the flow and enhance the observation.
Formation of Na-alginate emulsions and Ca-alginate microcapsules
In the experiments, the flow rates of the dispersed and the continuous phases were set to 1.0 µL min −1 . We found that the dispersed phase flow was compressed by a shear force to an arrow shape (see figure 6(b) , the outlet of the crossjunction channel) and then separated into emulsions of about 50 µm in diameter. In addition, the diameter distribution of the emulsions formed was quite uniform (50 ± 5 µm), and the gap between each emulsion was stable (75 ± 5 µm). At the cross junction, the water stream (dispersed phase) sent through the middle channel was sheared and cut by the oil stream (continuous phase) sent through the outer channel. The competition between interfacial tension and imposed pressure gradient (syringe pump) at the oil/water interface resulted in droplets of a finite diameter [32] . In addition, the arrow shape of the droplets was observed in the experiments. Generally, in a pressure-driven droplet flow, the front and rear droplets have different curvatures (the differential capillary pressures account for an axial pressure drop). According to the Bretherton problem [33] , the ends of the emulsion forming two hemispherical caps filling the cross-section of the tube involve infinite viscous stresses at the wall. The only physical forces maintaining the shape of the ends against these stresses are those due to the uniform pressure within the emulsion, surface tension and gravity. The flow rates of the dispersed and continuous phase were adjusted to control the degree of hydrodynamic focusing and the width of the center stream, resulting in the generation of size-controlled Na-alginate emulsions. Therefore, we concluded that hydrodynamic focusing can perform the emulsification in a size-controlled manner. In order to extract these emulsions for advanced applications, we solidified the Na-alginate emulsions by gelation. The continuous phase can prevent these semi-products from fusing together, and transport the semi-products (Naalginate emulsions) to the 20% (w/v) calcium chloride solution through a Teflon tube. Their higher density compared to that of the oil enables them to precipitate spontaneously at the bottom of the oil. Therefore, Na-alginate emulsions react with the calcium (II) ion at the interface between the oil and the aqueous phase. After the water-soluble Na-alginate emulsions have undergone crosslinking ( figure 3(b) ), they gel into solid capsules upon contact with the calcium (II) ion by means of external gelation, resulting in water-insoluble Caalginate microcapsules. Figure 6 shows the relationship between the average flow rate of the phases and the emulsion size (diameter); it is evident that the size and the gap of the emulsions generated in the cross-junction are controllable and reproducible by using the microfluidic platform. For any given 1.0 µL min −1 of the dispersed phase flow rate, the emulsion size decreases as the average flow rate of the continuous phase increases. The same tendency was observed in the other dispersed phase flow. Figure 8 . The UV-VIS spectrum of (a) IgG, Na-alginate solution and IgG-loaded Ca-alginate microcapsules and (b) 13 nm AuNPs, Na-alginate and AuNPs-loaded Ca-alginate microcapsules.
Influence of flow rate and viscosity
phase flow rate) can obtain smaller emulsions. Moreover, for any given 12.0 µL min −1 of continuous phase flow rate, the emulsion size increased as the average flow rate of the dispersed phase increased. The same tendency was observed in the other continuous phase flow. Figure 7(b) shows that increasing the dispersed phase flow rates (at a fixed continuous phase flow rate) results in larger emulsions and a linear regression trend. Furthermore, using the sheath focusing effect of the cross-junction to study the flow-rate dependence of the droplet size is a very well-studied phenomenon [26] [27] [28] [29] . Our results are similar to the previous studied [26] [27] [28] [29] .
In addition, the influence of the continuous phase viscosity on the emulsification was studied. We found that the average emulsion size also depends on the different viscosities in the continuous phases. These results are similar to the studies of Guillot and Colin [34] and Xu et al [35] . It was also found that the emulsion size decreases with the increase in the continuous phase rate and its viscosity, while at the same time being independent of the surface tension. Moreover, Babak et al [36] , Zhang et al [37] and Widom [38] investigated the fact that surfactants reduce the interface tension between oil phase and water phase, which enables them to be mixed and emulsify. Therefore, a relatively low surface tension of the emulsions indicates a better emulsification effect and a higher stability.
Encapsulation and analysis
Simply by mixing the water-soluble drugs with the Na-alginate solution well, an excellent level of entrapment efficiency can be observed. We first examined the encapsulation of IgG and AuNPs to verify the applicability of this microfluidic technique. Then a well-mixed mixture followed the general experimental procedure (as mentioned above) to obtain IgGloaded and AuNPs-loaded Ca-alginate microcapsules. The entrapment efficiency of IgG and AuNPs was determined by a UV spectrophotometer (HP 8453, Agilent, Germany).
We found that neat 1.5% (w/v) Na-alginates were not absorbent in UV-VIS, but after being mixed respectively with 1.0 mg/mL IgG (1.0 mg/mL IgG/1.5% (w/v) Naalginate in 1:1) and 0.1 nM 13 nm AuNPs (0.1 nM 13 nm AuNPs/1.5% (w/v) Na-alginate in 1:10) the absorbance with peaks of around 275 and 520 nm were observed. Furthermore, the absorption spectra of IgG-loaded and AuNPs-loaded Ca-alginate microcapsules showed the broad peaks of around 275 nm and 520 nm, as shown in figures 8(a) and (b), respectively, indicating that IgG and AuNPs were entrapped in the Ca-alginate microcapsules. It is worth noting that the absorption intensity results before and after gelation were similar. We presume that there is virtually no loss during the encapsulation process.
Conclusion
This study demonstrates microcapsule generation using a microfluidic device fabricated using an injection molding process similar to that employed in making optical disks. The industrial high-speed injection machine and the conventional optical disk mold were employed to fabricate the microfluidic disk. Therefore, the fabrication process proposed in this study is a time-saving, low-cost, flexible process. It has high-resolution, multi-functional structures on a uni-substrate, and it is suitable for mass production. In addition, this study demonstrates a microfluidic platform that utilizes a cross-junction microchannel enabling it to produce 20-50 µm Ca-alginate microcapsules with a narrow size distribution (<10%). We found that the continuous phase flow can pose a focusing/shear force on the dispersed phase flow in the microchannel. This adds to its use as a dynamic control of the emulsion size. Our platform is very attractive from a practical point of view, since it easily emulsifies and yields extremely uniform emulsions with a very high loading capacity. The approach of manipulating Ca-alginate microcapsules has many potential pharmaceutical applications.
